Doxorubicin Videos

FDA APPROVES HERCEPTIN FOR THE ADJUVANT TREATMENT OF HER2 POSITIVE NODE POSITIVE BREAST CANCERGenentech, Inc. announced today that the U.S. Food and Drug Administration FDA approved Herceptin Trastuzumab for the adjuvant treatment of HER2 positive node positive breast cancer, as part of a treatment regimen containing doxorubicin, cyclophosphamide, and paclitaxel. The FDA approval was based on data from an interim joint analysis of more than 3,500 patients enrolled in ...

FDA APPROVES HERCEPTIN FOR THE ADJUVANT TREATMENT OF HER2 POSITIVE NODE POSITIVE BREAST CANCERGenentech, Inc. announced today that the U.S. Food and Drug Administration FDA approved Herceptin Trastuzumab for the adjuvant treatment of HER2 positive node positive breast cancer, as part of a treatment regimen containing doxorubicin, cyclophosphamide, and paclitaxel. The FDA approval was based on data from an interim joint analysis of more than 3,500 patients enrolled in ...

HERCEPTIN REDUCED THE RISK OF BREAST CANCER RECURRENCE BY 52 PERCENT IN PIVOTAL STUDIES ONLY TARGETED BIOLOGIC THERAPY APPROVED FOR USE IN ADJUVANT AND METASTATIC HER2 POSITIVE BREAST CANCER Genentech, Inc. announced today that the U.S. Food and Drug Administration FDA approved Herceptin Trastuzumab for the adjuvant treatment of HER2 positive node positive breast cancer, as part of a treatment regimen containing doxorubicin, cyclophosphamide, and paclitaxel. The FDA approval w